Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting
Over the last decade, liquid biopsy has gained much attention as a powerful tool in personalized medicine since it enables monitoring cancer evolution and follow-up of cancer patients in real time. Through minimally invasive procedures, liquid biopsy provides important information through the analys...
Main Authors: | Areti Strati, Athina Markou, Evgenia Kyriakopoulou, Evi Lianidou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/7/2185 |
Similar Items
-
Liquid Biopsies: Emerging role and clinical applications in solid tumours
by: Sandeep Sisodiya, et al.
Published: (2023-09-01) -
A Review of Circulating Tumour Cell Enrichment Technologies
by: Amelia J. Rushton, et al.
Published: (2021-02-01) -
Detection of circulating tumour cells in the breast cancer using CytoTrack system
by: Bogacz Anna, et al.
Published: (2019-12-01) -
<i>ESR1</i> NAPA Assay: Development and Analytical Validation of a Highly Sensitive and Specific Blood-Based Assay for the Detection of <i>ESR1</i> Mutations in Liquid Biopsies
by: Dimitra Stergiopoulou, et al.
Published: (2021-02-01) -
Potential of circulating tumour DNA as a biomarker in liquid biopsy
by: Dimitar Dimitrov, et al.
Published: (2023-11-01)